£800,000 grant to boost the development of bacteriophages to combat disease

Pioneering work to develop effective and safe bacteriophages to combat disease has received an £800,000 boost.

Jazz’s KRAS deal with Redx; Alto Neuroscience upsizes IPO

Plus, news about PepGen and Jasper Therapeutics: Jazz Pharmaceuticals buys Redx Pharma’s KRAS inhibitors: The company is paying Redx $10 million upfront, with milestones up

February 8, 2024

From data to action: Igniting the healthcare revolution – Pharmaceutical Technology

As healthcare demands continue to surge, innovation is an ever-pressing necessity. At the heart of this transformation lies a precious resource, capable of revolutionising care

June 28, 2024

Researchers seek answers as they spell out Phase 3 failure of Bayer’s next-gen anticoagulant

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

September 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.